News & Insight
7 January 2021
People
Multidisciplinary collaboration driving new discoveries: uncovering the role of SLC7A5 in KRAS-driven colorectal cancer

New findings from the Rosetta team have identified the antiporter SLC7A5 as a target for KRAS-driven colorectal cancer.
We spoke with some of the co-authors to get their take on how a multidisciplinary team approach facilitated this…
Latest publication
Latest tweet

If you joined our webinar yesterday and you’re ready to start your application, don't forget to read our guidelines… https://t.co/akzhx7puyc Wed Jan 13 15:00:02 +0000 2021